Strafford
will be offering a webinar/teleconference on "Inducement to Infringe in Hatch-Waxman Litigation: Lessons from Commil USA v. Cisco Systems and Bayer Schering v. Lupin for Pharma
Patents" on August 21, 2013 from 1:00 to 2:30 pm (EDT). Thomas
L. Irving, Dr. David P. Frazier, and Robert F. Shaffer of Finnegan Henderson
Farabow Garrett & Dunner provide patent counsel with guidance on
claim and label language; to proactively coordinate patent, regulatory and
clinical personnel; and to maintain consistency between claims and likely or
actual label language throughout patent prosecution and label negotiation with
the FDA. The webinar will review the
following questions:
•
What can be learned from the AstraZeneca v. Apotex, Bayer Schering v.
Lupin, and Commil USA v. Cisco Systems Inc. decisions?
•
What are the best approaches to maintain consistency between claims and likely
or actual label language?
•
What steps can be taken to maintain the coordination of patent, regulatory and
clinical personnel throughout the patent prosecution and label negotiation with
the FDA?
The
registration fee for the webinar is $297 ($362 for registration and CLE processing). Those registering by July 26, 2013 will
receive a $50 discount. Those interested
in registering for the webinar, can do so here.
Comments